Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice
Jc. Alvarez et al., Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice, EUR NEUROPS, 10(1), 1999, pp. 31-36
The aim of the study was to compare in male NMRI mice the simultaneous evol
ution of blood serotonin (5-HT) concentrations, which correspond to 99% of
platelet 5-HT content, and 5-HT parameters in the dorsal raphe, caudate nuc
leus and frontal cortex after clomipramine? fluoxetine and moclobemide trea
tments. After steady-state concentrations of the three compounds were reach
ed, the 5-HT levels were significantly enhanced vs. saline-treated mice in
the three brain areas studied. Tryptophan (TRP) levels in the three brain a
reas were significantly increased with clomipramine and fluoxetine but not
with moclobemide. A significant decrease in the metabolite 5-hydroxyindolea
cetic acid (5-HIAA) levels was observed only with moclobemide. After 14 day
s of treatment, 5-HT levels in all areas studied were found to be enhanced
only with moclobemide while TRP and 5-HIAA levels were not different under
the three drug regimes from those of controls. After 21 days of treatment,
5-HT levels were found enhanced only with moclobemide in the nerve terminal
regions. An important depletion in platelet 5-HT content was observed afte
r clomipramine and fluoxetine treatments at day 14 and day 21 and a signifi
cant increase was observed after moclobemide treatment at day 14 with a ret
urn to initial values after 21 days. Our results show significantly differe
nt effects between central and peripheral indices of 5-HT metabolism accord
ing to time and to the antidepressant assessed: (i) an enhancement of total
tissue 5-HT levels in the three brain areas studied after steady-state ach
ievement of the 3 antidepressants, (ii) the return to initial values of bra
in 5-HT levels after repeated administration of the two 5-HT re-uptake inhi
bitors, consistent with the presence of brain adaptative mechanisms, with a
concomittant dramatic decrease of platelet 5-HT content and (iii) an appar
ent gradual attenuation of the brain and periphery MAOI-A effect induced by
moclobemide with 5-HT levels remaining elevated only in 5-HT nerve termina
l regions. (C) 1999 Elsevier Science B.V. All rights reserved.